Pre-medication ADHD screening
Gima R. Gima R.

Pre-medication ADHD screening

Learn why pre-medication ADHD screening matters, what it includes, and how it helps determine whether ADHD medication is safe and appropriate.

Read More
The 19 QT-Prolonging Drugs Every ADHD Prescriber Needs to Know About
Jeffrey Jeffrey

The 19 QT-Prolonging Drugs Every ADHD Prescriber Needs to Know About

When we talk about drug safety in ADHD prescribing, the conversation usually starts with cardiovascular contraindications. These are the headline stops. Every prescriber knows them. What gets less attention is the patient on citalopram 40mg who wants to start atomoxetine. Or the patient on quetiapine and haloperidol where the QT risk compounds. Here are the 19 QT-prolonging drugs every ADHD prescriber needs to know — tiered by risk, with guidance on what your documentation needs to show.

Read More
Why ADHD Pre-Medication Screening Is the Highest-Risk Step in the Private Prescribing Pathway — And What to Do About It
Jeffrey Jeffrey

Why ADHD Pre-Medication Screening Is the Highest-Risk Step in the Private Prescribing Pathway — And What to Do About It

If you prescribe ADHD medication privately, you already know the feeling. A patient in front of you. Confirmed diagnosis. Ready to start medication. And before you can write that prescription, you need to work through a mental checklist that isn't written down anywhere in one place. Ten absolute contraindications for lisdexamfetamine alone. Thirteen for methylphenidate — several unique to that drug. QT prolongation profiles. Named MAOIs. Baseline observations. ECG indications. The risk isn't that prescribers don't know this. The risk is that without a structured, documented process — the screening and the documentation aren't consistent. And inconsistency is where medico-legal exposure begins. Here's what good pre-initiation screening actually looks like, and what I built to solve it.

Read More
Hypermobility and ADHD: Is There a Connection?
Gima R. Gima R.

Hypermobility and ADHD: Is There a Connection?

Research shows 50% of ADHD adults are hypermobile—5x higher than average. Discover the genetic, autonomic links between hypermobility/EDS and ADHD, daily life impact, and UK assessment options. If joint pain + brain fog sound familiar, this could explain why.

Read More
ADHD and OCD: can you have both?
Gima R. Gima R.

ADHD and OCD: can you have both?

Yes, you can have both ADHD and OCD. They are different conditions, but they can overlap, affect each other, and sometimes be mistaken for one another. This article explains the differences, the overlap, and what to do if you think you may have both.

If you have symptoms that feel confusing or contradictory, a proper assessment can help clarify what is driving them and what treatment may help.

Read More
PMDD and ADHD: What is the link?
Gima R. Gima R.

PMDD and ADHD: What is the link?

PMDD and ADHD can happen together, and the combination can make symptoms feel more intense across the menstrual cycle. This article explains what PMDD is, why it often overlaps with ADHD, how hormones can affect symptoms, and what treatment options may help.

If you think you may have both conditions, the most important step is to discuss the pattern of your symptoms with a clinician who understands both ADHD and menstrual health.

Read More
Non-stimulant ADHD medications: a complete guide
Gima R. Gima R.

Non-stimulant ADHD medications: a complete guide

Non-stimulant ADHD medications can be a useful option for adults who cannot tolerate stimulants, do not get enough benefit from them, or prefer a different treatment approach. This guide explains what non-stimulants are, how atomoxetine and guanfacine work, and how they compare with stimulant medicines.

Read More
Adderall for ADHD in Adults: Evidence, Risks and UK‑Approved Alternatives
Gima R. Gima R.

Adderall for ADHD in Adults: Evidence, Risks and UK‑Approved Alternatives

This clinical, evidence‑based guide is written for adults searching for “Adderall for ADHD” who want a clear explanation of what Adderall is, how it works in adult ADHD, why it is rarely used in the UK, and which UK‑licensed medicines fulfil the same therapeutic role with proper monitoring. It is information, not personalised medical advice; any decision about treatment should be made with a suitably qualified prescriber.

Read More